{"id":3598,"date":"2026-06-18T13:41:10","date_gmt":"2026-06-18T13:41:10","guid":{"rendered":"https:\/\/indiamedicine.org\/?p=3598"},"modified":"2026-06-18T13:41:10","modified_gmt":"2026-06-18T13:41:10","slug":"how-to-verify-indian-generic-medicine-quality-checklist-international-buyers","status":"publish","type":"post","link":"https:\/\/indiamedicine.org\/?p=3598","title":{"rendered":"How to Verify Indian Generic Medicine Quality: A Practical Checklist for International Buyers"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">&#x1f4cb; Why Verification Matters When Sourcing from India<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">India supplies over <strong>20% of the world&#8217;s generic medicines by volume<\/strong> (GTRI, May 2026) and 60% of global vaccine demand. For international buyers \u2014 distributors, hospitals, pharmacies, and procurement agencies \u2014 the cost savings are significant (typically 80\u201390% vs. branded equivalents). But quality varies by facility. A systematic verification process protects your supply chain and patients.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x1f3db;&#xfe0f; Core Regulatory Authorities to Know<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>CDSCO (Central Drugs Standard Control Organization)<\/strong> \u2014 India&#8217;s national drug regulator. Approves manufacturing licenses (Form 25\/28), new drugs, and export NOCs.<\/li>\n<li><strong>State Drug Controllers<\/strong> \u2014 Issue manufacturing licenses and WHO-GMP certificates at the state level. Each state has its own portal.<\/li>\n<li><strong>Pharmexcil<\/strong> \u2014 Export promotion council. Issues RCMC (Registration-Cum-Membership Certificate) confirming export eligibility.<\/li>\n<li><strong>DGFT (Directorate General of Foreign Trade)<\/strong> \u2014 Issues IEC (Import Export Code) mandatory for all cross-border trade.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">&#x2705; 10-Point Manufacturer Verification Checklist<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Before placing an order, confirm each item below. Request documents directly from the manufacturer \u2014 legitimate suppliers provide them routinely.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1. CDSCO Manufacturing License (Form 25\/28)<\/h3>\n\n\n<p class=\"wp-block-paragraph\"><strong>What:<\/strong> License to manufacture drugs for sale\/distribution.<br><strong>Verify:<\/strong> Check the state drug controller portal (e.g., <a href=\"https:\/\/fdakarnataka.kar.nic.in\" target=\"_blank\" rel=\"noopener\">Karnataka FDA<\/a>, <a href=\"https:\/\/www.mahafda.gov.in\" target=\"_blank\" rel=\"noopener\">Maharashtra FDA<\/a>, <a href=\"https:\/\/www.gujaratfdca.nic.in\" target=\"_blank\" rel=\"noopener\">Gujarat FDCA<\/a>). License must be current and match the facility address.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2. WHO-GMP Certificate<\/h3>\n\n\n<p class=\"wp-block-paragraph\"><strong>What:<\/strong> Good Manufacturing Practices certificate issued by state FDA after inspection, valid 3 years.<br><strong>Verify:<\/strong> Certificate must show scope (which products\/sections), issue date, and validity. Cross-reference with WHO prequalified list at <a href=\"https:\/\/extranet.who.int\/prequal\" target=\"_blank\" rel=\"noopener\">extranet.who.int\/prequal<\/a>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3. COPP (Certificate of Pharmaceutical Product)<\/h3>\n\n<!-- \/wp:post-content -->\n<!-- wp:paragraph -->\n<p><strong>What:<\/strong> WHO-format certificate confirming the product is licensed in India and the manufacturer complies with GMP. Required by most importing countries.<br><strong>Verify:<\/strong> Must be product-specific, issued by the state drug controller, and current (typically valid 2\u20133 years).<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\">4. USFDA \/ EMA \/ PMDA \/ TGA Inspection History<\/h3>\n<!-- \/wp:heading -->\n<!-- wp:paragraph -->\n<p><strong>What:<\/strong> Inspection records from stringent regulatory authorities (SRA).<br><strong>Verify:<\/strong> Check <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/\" target=\"_blank\" rel=\"noopener\">FDA Drugs@FDA<\/a> (establishment inspection reports), <a href=\"https:\/\/www.ema.europa.eu\/en\/inspections\" target=\"_blank\" rel=\"noopener\">EMA GMP compliance<\/a>, <a href=\"https:\/\/www.pmda.go.jp\/english\/\" target=\"_blank\" rel=\"noopener\">PMDA<\/a>, <a href=\"https:\/\/www.tga.gov.au\" target=\"_blank\" rel=\"noopener\">TGA<\/a>. A clean inspection history (no OAI\/Warning Letters) is a strong quality signal.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\">5. Pharmexcil RCMC<\/h3>\n<!-- \/wp:heading -->\n<!-- wp:paragraph -->\n<p><strong>What:<\/strong> Registration-Cum-Membership Certificate confirms the company is an eligible exporter.<br><strong>Verify:<\/strong> Check validity on Pharmexcil portal or request a copy. Not a quality certificate per se, but confirms legitimate export status.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\">6. Batch-Specific Certificate of Analysis (CoA)<\/h3>\n<!-- \/wp:heading -->\n<!-- wp:paragraph -->\n<p><strong>What:<\/strong> QC test results for each batch: assay, impurities, dissolution, microbial limits, heavy metals.<br><strong>Verify:<\/strong> Demand CoA for <strong>every batch<\/strong>. Cross-check against pharmacopeial specs (IP\/USP\/EP). Look for: batch number, manufacturing\/expiry dates, analyst signatures, QC lab stamp.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\">7. Stability Data (Real-Time &#038; Accelerated)<\/h3>\n<!-- \/wp:heading -->\n<!-- wp:paragraph -->\n<p><strong>What:<\/strong> Evidence the product remains within specs throughout shelf life under recommended storage conditions.<br><strong>Verify:<\/strong> Manufacturer should provide stability protocol and summary data (ICH Q1A). Critical for products with cold-chain requirements.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\">8. Pharmacovigilance System Compliance<\/h3>\n<!-- \/wp:heading -->\n<!-- wp:paragraph -->\n<p><strong>What:<\/strong> Manufacturer has a qualified person responsible for pharmacovigilance (QPPV) and adverse event reporting SOPs.<br><strong>Verify:<\/strong> Request PV system summary. Mandatory under NDCT Rules 2019 for exporters to regulated markets.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\">9. Revised Schedule M Compliance (2023 Notification)<\/h3>\n<!-- \/wp:heading -->\n<!-- wp:paragraph -->\n<p><strong>What:<\/strong> India&#8217;s revised Schedule M (Dec 2023) aligns domestic GMP with WHO-GMP: mandatory ICH Q9 risk management, Pharmaceutical Quality System (PQS), data integrity, validation master plan.<br><strong>Verify:<\/strong> Ask for the facility&#8217;s PQS summary and data integrity policy. Large manufacturers (turnover >\u20b9250 crore) had Dec 2024 deadline; SMEs have until Dec 2025\u2013Jun 2026 (extension debates ongoing per Mint, Dec 2025).<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:heading {\"level\":3} -->\n<h3 class=\"wp-block-heading\">10. IMSDA Membership &#038; Industry Standing<\/h3>\n<!-- \/wp:heading -->\n<!-- wp:paragraph -->\n<p><strong>What:<\/strong> IMSDA members maintain valid CDSCO-compliant licenses as a membership condition. Gold members represent the highest compliance tier.<br><strong>Verify:<\/strong> Check the <a href=\"https:\/\/indiamedicine.org\/?page_id=1454\">IMSDA verified member directory<\/a>. Membership indicates commitment to quality and ethical practices.<\/p>\n<!-- \/wp:paragraph -->\n\n<!-- wp:separator {\"className\":\"has-alpha-channel-opacity\"} -->\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n<!-- \/wp:separator -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\">&#x1f4cb; Quick-Reference Verification Table<\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:table -->\n<figure class=\"wp-block-table\"><table><thead><tr><th>Check Item<\/th><th>Document to Request<\/th><th>Verifying Authority \/ Source<\/th><th>Red Flags<\/th><\/tr><\/thead><tbody><tr><td>Manufacturing License<\/td><td>Form 25\/28 copy<\/td><td>State Drug Controller portal<\/td><td>Expired, mismatched address, product not in scope<\/td><\/tr><tr><td>WHO-GMP<\/td><td>Certificate (3-yr validity)<\/td><td>State FDA \/ WHO prequal list<\/td><td>Expired, limited scope, not on WHO list<\/td><\/tr><tr><td>COPP<\/td><td>Product-specific COPP<\/td><td>State Drug Controller<\/td><td>Missing, expired, product not listed<\/td><\/tr><tr><td>SRA Inspections<\/td><td>EIR \/ GMP certificate<\/td><td>FDA \/ EMA \/ PMDA \/ TGA databases<\/td><td>OAI classification, Warning Letter, import alert<\/td><\/tr><tr><td>Batch CoA<\/td><td>CoA per batch<\/td><td>Manufacturer QC lab<\/td><td>Missing tests, out-of-spec results, no signatures<\/td><\/tr><tr><td>Stability Data<\/td><td>Protocol + summary<\/td><td>Manufacturer \/ ICH Q1A<\/td><td>No real-time data, gaps in timeline<\/td><\/tr><tr><td>Schedule M Compliance<\/td><td>PQS summary, DI policy<\/td><td>Facility self-declaration \/ audit<\/td><td>No PQS, no data integrity controls<\/td><\/tr><tr><td>Pharmacovigilance<\/td><td>QPPV details, SOP<\/td><td>Manufacturer \/ NDCT Rules<\/td><td>No QPPV, no AE reporting process<\/td><\/tr><\/tbody><\/table><\/figure>\n<!-- \/wp:table -->\n\n<!-- wp:separator {\"className\":\"has-alpha-channel-opacity\"} -->\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n<!-- \/wp:separator -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\">&#x26a0;&#xfe0f; Common Pitfalls &#038; How to Avoid Them<\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:list -->\n<ul class=\"wp-block-list\">\n<li><strong>Pitfall:<\/strong> Assuming CDSCO approval = automatic eligibility in your country<br><strong>Fix:<\/strong> Each country has sovereign approval \u2014 verify destination requirements independently<\/li>\n<li><strong>Pitfall:<\/strong> Relying on trader\/intermediary documents without verifying the actual manufacturer<br><strong>Fix:<\/strong> Always trace back to the manufacturing site license; confirm trader&#8217;s Form 20B\/21B wholesale license and IEC<\/li>\n<li><strong>Pitfall:<\/strong> Accepting a single CoA for multiple batches<br><strong>Fix:<\/strong> Demand batch-specific CoA for every shipment<\/li>\n<li><strong>Pitfall:<\/strong> Ignoring temperature excursions during transit<br><strong>Fix:<\/strong> Use data loggers; require cold-chain validation for biologics\/insulins<\/li>\n<li><strong>Pitfall:<\/strong> Overlooking the revised Schedule M transition period<br><strong>Fix:<\/strong> Ask specifically about PQS implementation and data integrity controls \u2014 not just &#8220;GMP certified&#8221;<\/li>\n<\/ul>\n<!-- \/wp:list -->\n\n<!-- wp:separator {\"className\":\"has-alpha-channel-opacity\"} -->\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n<!-- \/wp:separator -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\">&#x1f517; Trusted Resources for Ongoing Verification<\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:list -->\n<ul class=\"wp-block-list\">\n<li><strong>WHO Prequalified Medicines:<\/strong> <a href=\"https:\/\/extranet.who.int\/prequal\" target=\"_blank\" rel=\"noopener\">extranet.who.int\/prequal<\/a><\/li>\n<li><strong>FDA Establishment Inspection Reports:<\/strong> <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/\" target=\"_blank\" rel=\"noopener\">accessdata.fda.gov\/scripts\/cder\/daf<\/a><\/li>\n<li><strong>EMA GMP Compliance:<\/strong> <a href=\"https:\/\/www.ema.europa.eu\/en\/inspections\" target=\"_blank\" rel=\"noopener\">ema.europa.eu\/en\/inspections<\/a><\/li>\n<li><strong>CDSCO Official Website:<\/strong> <a href=\"https:\/\/cdsco.gov.in\" target=\"_blank\" rel=\"noopener\">cdsco.gov.in<\/a><\/li>\n<li><strong>Pharmexcil Member Directory:<\/strong> <a href=\"https:\/\/www.pharmexcil.com\" target=\"_blank\" rel=\"noopener\">pharmexcil.com<\/a><\/li>\n<li><strong>IMSDA Verified Member Directory:<\/strong> <a href=\"https:\/\/indiamedicine.org\/?page_id=1454\">indiamedicine.org\/?page_id=1454<\/a><\/li>\n<\/ul>\n<!-- \/wp:list -->\n\n<!-- wp:separator {\"className\":\"has-alpha-channel-opacity\"} -->\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n<!-- \/wp:separator -->\n\n<!-- wp:heading -->\n<h2 class=\"wp-block-heading\">&#x1f4da; Sources<\/h2>\n<!-- \/wp:heading -->\n\n<!-- wp:list -->\n<ul class=\"wp-block-list\">\n<li>GTRI \u2014 India Supplies 20% of Global Generic Medicines (May 2026)<\/li>\n<li>CDSCO \u2014 Revised Schedule M Notification (Dec 2023) and 2026 Implementation Updates<\/li>\n<li>Business Standard \u2014 CDSCO Tightens Quality Net with Audits, Scientific Cadre Overhaul (Feb 2026)<\/li>\n<li>Medical Dialogues \u2014 CDSCO, DoP Told to Find Workable Solution on Revised Schedule M GMP Concerns (Jan 2026)<\/li>\n<li>Mint \u2014 Govt Mulls Extension for Pharma New Manufacturing Practice Norms (Dec 2025)<\/li>\n<li>WHO \u2014 Guidelines on Good Manufacturing Practices (Technical Report Series)<\/li>\n<li>ICH Q1A \u2014 Stability Testing of New Drug Substances and Products<\/li>\n<li>ICH Q9 \u2014 Quality Risk Management<\/li>\n<li>NDCT Rules 2019 (Amended 2026) \u2014 Pharmacovigilance Requirements for Exporters<\/li>\n<\/ul>\n<!-- \/wp:list -->\n\n<!-- wp:separator {\"className\":\"has-alpha-channel-opacity\"} -->\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n<!-- \/wp:separator -->\n\n<!-- wp:paragraph -->\n<p>For more information, contact IMSDA at contact@indiamedicine.org.<\/p>\n<!-- \/wp:paragraph -->","protected":false},"excerpt":{"rendered":"<p>&#x1f4cb; Why Verification Matters When Sourcing from India India supplies over 20% of the world&#8217;s generic medicines by volume (GTRI, May 2026) and 60% of global vaccine demand. For international buyers \u2014 distributors, hospitals, pharmacies, and procurement agencies \u2014 the cost savings are significant (typically 80\u201390% vs. branded equivalents). But quality varies by facility. A [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[42,48,29,49],"class_list":["post-3598","post","type-post","status-publish","format-standard","hentry","category-knowledge","tag-cdsco","tag-generic-medicines","tag-india-pharmacy","tag-indian-pharma","entry"],"_links":{"self":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts\/3598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3598"}],"version-history":[{"count":0,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts\/3598\/revisions"}],"wp:attachment":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}